Portfolio company short bio
HCS PHARMA is a biotechnology company that develops and markets 3D cell culture products based on its exclusive and proprietary BIOMIMESYS® technology and develops its own 3D cell models that it offers to these customers.
Portfolio Company Info
BIOMIMESYS® 3D culture technology is a groundbreaking technology faithfully reproduces the natural microenvironment of the cells of a target organ.
Founder/CEO name: Nathalie Maubon (LinkedIn)
Request a contact
Location: Loos, France
Sector: Biotech; Health; 3D technology
Total amount raised (mln EUR): 0.80
Employees range: 11-50